Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marco Galliano"'
Autor:
Franco Testore, Antonio Santo, Emanuele Naglieri, Laura Ridolfi, Marco Galliano, Monica Maglie, Ruggero Ridolfi, Massimo Lopez, Oscar Bertetto, Francesco Recchia, Monia Dall'agata, Paolo Lissoni, Luca Fumagalli, Camillo Porta
Publikováno v:
International Journal of Oncology.
Non-small cell lung cancer (NSCLC) is associated with IL-2-dependent cell-mediated immunodeficiency. As IL-2 is the main lymphocyte growth factor, a phase III randomized multicenter trial was conducted to evaluate the impact of subcutaneous low-dose
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 1, Iss 1, p 35 (2006)
Radiation Oncology, Vol 1, Iss 1, p 35 (2006)
Mantle Cell Lymphoma (MCL) is a well-known histological and clinical subtype of B-cell non-Hodgkin's Lymphomas. It is usually characterized by an aggressive disease course, presenting with advanced stage disease at diagnosis and with low response rat
Autor:
Giuseppe Spinoglio, Narciso Mariani, Federica Grosso, Marco Galliano, Maura Rossi, Vittorio Fusco, Silvia Zai, Sara Orecchia, Elisa Bennicelli, Roberta Libener, Pamela Guglielmini, Pierluigi Piovano
Publikováno v:
Journal of Clinical Oncology. 31:e14657-e14657
e14657 Background: KRAS and BRAF mutations have prognostic and predictive value in colorectal cancer and are predominantly mutually exclusive. Only a few cases of double mutations (DM) have been reported so far but the actual incidence and presumed r